Skip to content

TAMIR BIOTECHNOLOGY, INC.

CIK 0000708717

← back to feed
Revenue (TTM)
$0
−90.4% YoY Q3 May 2013
Net Income (TTM)
−$616.91K
−86.1% YoY Q3 May 2013
EPS Diluted (TTM)
−$0.05
−20.0% YoY Q3 May 2013
Gross Margin
—
Q3 May 2013
Operating Margin
—
Q3 May 2013
Net Margin
—
Q3 May 2013
Free Cash Flow (TTM)
−$360.16K
Q3 May 2013
Cash
$782.57K
Q3 May 2013
Total Debt
—
Q3 May 2013
Shares Outstanding
217.36M sh
Q3 May 2013

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings